SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

ESTA

ESTABLISHMENT LABS HOLDINGS INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001688757-26-000031
Proxy solicitation materials
Actionable Insight • Neutral

No trading implication; this is a routine correction of disclosed compensation data. Monitor the upcoming annual meeting for any unstated governance concerns, though none are evident here.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ESTA ▲ +43.38% at T+60d
NEUTRAL call +43.38% · α vs SPY +38.60% · entry $65.47 → $93.87
Entry = T+0 close
Apr 24, 2026
via day close
T+1d
-1.63%
call -1.63% · α -1.15%
$64.40
settled 6mo ago
T+5d
+7.29%
call +7.29% · α +6.89%
$70.24
settled 6mo ago
T+20d
+10.95%
call +10.95% · α +6.00%
$72.64
settled 5mo ago
T+60d
+43.38%
call +43.38% · α +38.60%
$93.87
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Establishment Labs issued a proxy supplement to correct a typographical error in its 2025 non-employee director compensation table, revising stock award values for several directors. The correction adjusts previously overstated figures, with Juan José Chacón Quirós now shown receiving $499,975 in stock awards and others $124,984, aligning with actual grants.

Key Financial Metrics

Vote
director election
Meeting
2026-05-22

Key Facts

  • Filing is a corrective supplement to the 2026 proxy statement, addressing a typo in the 2025 non-employee director compensation table.
  • Stock awards for Juan José Chacón Quirós were corrected from $374,946 to $499,975; for Ann Custin, Leslie Gillin, Nicholas Lewin, Edward J. Schutter, and Bryan Slotkin from $374,946 to $124,984.
  • Total compensation figures for the affected directors were updated accordingly.
  • No changes to corporate governance, strategy, or financial performance are indicated.
  • The filing was made by the registrant (management) and does not reflect shareholder activism or dissident action.

Financial Impact

Minimal; no financial impact beyond correcting previously disclosed compensation values.

director_compensation

Risk Factors

  • Perception of weak internal controls if repeated errors occur.
  • Minimal reputational risk from disclosure inaccuracies.

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001688757-26-000031
Document: 0001688757-26-000031-index-headers.html0001688757-26-000031
Document: 0001688757-26-000031-index.html0001688757-26-000031
Document: 0001688757-26-000031.txt0001688757-26-000031
8 reports for ESTA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ESTA — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
8-K
NEUTRAL ★ 3/10
$61.36awaiting T+60—$66.95 (+9.11%)
Aug 6, 2026
11w ago
8-K
MIXED ★ 6/10
$79.05awaiting T+60—$66.95 (−15.31%)
Jun 29, 2026
17w ago
3
NEUTRAL ★ 1/10
$85.81 $67.76▼ −21.03%▼ −23.85%$66.95 (−21.98%)
Jun 29, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$87.42 $70.24▼ −19.65%▼ −24.04%$66.95 (−23.42%)
May 6, 2026
24w ago
8-K
BULLISH ★ 8/10
$74.54 $92.54▲ +24.15%▲ +22.09%$66.95 (−10.18%)
May 6, 2026
24w ago
Insider Cluster
BEARISH ★ 6/10
$74.54 $92.54▼ −24.15%▼ −22.09%$66.95 (+10.18%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$65.47 $93.87▲ +43.38%▲ +38.60%$66.95 (+2.26%)
Apr 10, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$62.92 $87.99▲ +39.84%▲ +30.92%$66.95 (+6.40%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (17h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026